Product Images Layolis Fe
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Layolis Fe NDC 52544-064 by Actavis Pharma, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
PRINCIPAL DISPLAY PANELLilettaLayolis™ Fe (norethindrone and ethinyl estradiol chewable tablets and ferrous fumarate chewable tablets) 0.8 mg/25 mcgNDC 52544-064-31Carton x Three 28-Tablet Dispensers - layolis fe 01
This text provides a list of studies related to the risk of breast cancer with the use of combined oral contraceptives. The studies include the names of the research, the authors, and the effect estimate. Specifically, it mentions studies like HICHO Women's Care Study, French ESN cohort study, and Shanghai Women's Health Study, among others.*
layolis fe 02
layolis fe 03
layolis fe 04
This text appears to be describing pregnancy rates, with a comparison of less than 1 pregnancy per 100 women in one year versus 85 or more pregnancies per 100 women in one year. The text also mentions a total of 1020 pregnancies per 100 women in one year.*
layolis fe 05
layolis fe 06
Layolis Fe is a medication that comes in chewable tablets containing norethindrone and ethinyl estradiol, as well as ferrous fumarate. It is manufactured by Actavis and contains 0.8mg/25mcg of the active ingredients.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.